Smilow Cancer Hospital-Orange Care Center
Orange, Connecticut, United States
Cancer treatment center in Orange, Connecticut
240 Indian River Rd building a suite 1a, Orange, CT 06477
About Smilow Cancer Hospital-Orange Care Center
"At Smilow Cancer Hospital Care Centers, we offer state-of-the-art cancer services at several convenient locations throughout the region."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Smilow Cancer Hospital-Orange Care Center
During the past decade, Smilow Cancer Hospital-Orange Care Center conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 21 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 16 clinical trials were completed. i.e. 266.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
2002-12-01
2015-04-01
Completed
226
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
2003-01-01
2004-10-01
Terminated
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Smilow Cancer Hospital-Orange Care Center" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "SWOG Cancer Research Network" with 23 trials
sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "NRG Oncology"
with 3 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Smilow Cancer Hospital-Orange Care Center"
#1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Smilow Cancer Hospital-Orange Care Center
According to Clinical.Site data, the most researched conditions in "Smilow Cancer Hospital-Orange Care Center" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "HER2/Neu Negative" (4 trials), "Invasive Breast Carcinoma" (4 trials) and "Stage III Breast Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Smilow Cancer Hospital-Orange Care Center" in a lesser frequency.
Clinical Trials Intervention Types at Smilow Cancer Hospital-Orange Care Center
Most popular intervention types in "Smilow Cancer Hospital-Orange Care Center" are "Drug" (55 trials), "Other" (48 trials), "Biological" (33 trials), "Procedure" (15 trials) and "Radiation" (5 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "Quality-of-Life Assessment" (19 trials), "Computed Tomography" (13 trials), "Questionnaire Administration" (11 trials) and "Biospecimen Collection" (10 trials). Other intervention names were less common.
Clinical Trials Genders at Smilow Cancer Hospital-Orange Care Center
The vast majority of trials in "Smilow Cancer Hospital-Orange Care Center" are
57 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Smilow Cancer Hospital-Orange Care Center
Currently, there are NaN active trials in "Smilow Cancer Hospital-Orange Care Center".
undefined are not yet recruiting,
18 are recruiting,
35 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Smilow Cancer Hospital-Orange Care Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Smilow Cancer Hospital-Orange Care Center, 4 "Phase 1"
clinical trials were conducted, 32 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".